Equity Overview
Price & Market Data
Price: $4.00
Daily Change: $0.00 / 0.00%
Daily Range: $4.00 - $4.00
Market Cap: $75,018,960
Daily Volume: 500
Performance Metrics
1 Week: 25.00%
1 Month: 25.00%
3 Months: 25.00%
6 Months: 25.00%
1 Year: -20.32%
YTD: %
About RetinalGenix Technologies Inc. (RTGN)
Comprehensive data for RetinalGenix Technologies Inc. (RTGN). Price: 4.00, daily change: $0.00 / 0.00%. Market cap: 75,018,960. Performance over 3-month, 6-month, and 52-week periods.
Details
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.